The nation of Zimbabwe has rejected a major US health deal worth $367m (£272m) over five years because of the United States' request for sensitive biological samples.
This rejection came to light after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "lopsided".
A government representative later explained that the US was seeking biological samples for research and commercial gain while was not willing to guarantee the benefits from any future vaccines.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for further talks to find a agreement agreeable to all parties so the country's vital HIV programme can be sustained.
Broader Background
This development follows a similar case in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were raised about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and responsibility.
According to statements, 16 African countries have to date signed these new health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, without any corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"In essence, our nation would supply the basic resources for medical research with no certainty that the final treatments would be available to our people if a future disease outbreak arise."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already established through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.
"This system is designed to ensure that when a nation contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to create them."
These objections regarding the US deal "are not meant as opposition to America," he added.
"We welcome further dialogue with our US partners on how subsequent collaboration could be designed in a manner that respects the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but recommended that talks must proceed since a large portion of the country's HIV programmes were funded by external financing.
"If specific concerns exist, such as those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.
The halted deal underscores the continuing tensions between receiving crucial foreign assistance and protecting local interests in an ever more interconnected world.